Eoin P. Flanagan MB, BChAssociate Professor of Neurology and Consultant in the Departments of Neurology and Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota
Dr. Eoin Flanagan is an Associate Professor of Neurology and Consultant in the departments of Neurology and Laboratory Medicine and Pathology at the Mayo Clinic (Rochester, MN). He completed his medical school training at University College Dublin in Ireland in 2005. He completed medical residency in Ireland and became a member of the Royal College of Physicians of Ireland in 2008. He then pursued neurology residency at Mayo Clinic (Rochester, MN) and is board certified in neurology in the USA. He completed fellowships in autoimmune neurology, multiple sclerosis and behavioral neurology at Mayo Clinic. He received a Master’s degree in clinical and translational science at Mayo Clinic. He works in the Autoimmune and Multiple Sclerosis Neurology Clinics and the Neuroimmunology Laboratory at the Mayo Clinic. His clinical expertise and research is focused on the diagnosis and management of autoimmune neurological disorders with an emphasis on inflammatory autoimmune spinal cord disorders and their mimics including their MRI patterns. He also has an interest in the epidemiology of inflammatory demyelinating diseases of the central nervous system and autoimmune neurologic disorders.
Dr. Flanagan is a site principal investigator in a randomized placebo-controlled clinical trial of Inebilizumab (A CD19 inhibitor) in neuromyelitis optica spectrum disorders funded by MedImmune/Viela Bio. He receives no personal compensation and just receives reimbursement for the research activities related to the trial.